Latest News for: naltrexone
Edit
Nota Informativa Importante su Mysimba (naltrexone/bupropione) Notizia in evidenza (Italian Medicines Agency)
Public Technologies 29 May 2025
[...]. This is an abstract of the document. To keep reading, click here and get access to the original version. Attachments Original document Permalink. Disclaimer.
- 1